Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente CURRENT MEDICINAL CHEMISTRY

Tipo Año Título Fuente
Editorial2022Prof. Jesús Jiménez-Barbero: Disentangling Molecular Recognition of CarbohydratesCURRENT MEDICINAL CHEMISTRY
Revisión2020Carbohydrates: Potential Sweet Tools against CancerCURRENT MEDICINAL CHEMISTRY
Revisión2019Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium SignalingCURRENT MEDICINAL CHEMISTRY
Revisión2016Pharmacological Effects of Niacin on Acute HyperlipemiaCURRENT MEDICINAL CHEMISTRY
Artículo2016Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's DiseaseCURRENT MEDICINAL CHEMISTRY
Artículo2015A Simple and Reliable Approach for Assessing Anticancer Activity In VitroCURRENT MEDICINAL CHEMISTRY
Artículo2015Chalcones as Promising Lead Compounds on Cancer TherapyCURRENT MEDICINAL CHEMISTRY
Revisión2014Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A ReviewCURRENT MEDICINAL CHEMISTRY
Artículo2014Oxidative Stress in Traumatic Brain InjuryCURRENT MEDICINAL CHEMISTRY
Artículo2013An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical ImplicationsCURRENT MEDICINAL CHEMISTRY
Artículo2013Recent Developments on Synthetic Tools Towards Structural and Functional GlycodiversityCURRENT MEDICINAL CHEMISTRY
Revisión2012Drug targeting to cancer by nanoparticles surface functionalized with special biomoleculesCURRENT MEDICINAL CHEMISTRY
Revisión2012Melatonin, A Natural Programmed Cell Death Inducer in CancerCURRENT MEDICINAL CHEMISTRY
Revisión2012Sirtuin Modulators: Mechanisms and Potential Clinical ImplicationsCURRENT MEDICINAL CHEMISTRY
Revisión2011Immunophilins and Cardiovascular ComplicationsCURRENT MEDICINAL CHEMISTRY
Revisión2011Nanostructures for Drug Delivery to the BrainCURRENT MEDICINAL CHEMISTRY
Revisión2011Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase InhibitorsCURRENT MEDICINAL CHEMISTRY
Revisión2004Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons: possible relevance to the etiology of Parkinson's diseaseCURRENT MEDICINAL CHEMISTRY